Abstract | STUDY OBJECTIVE: DESIGN: Randomized double-blind crossover trial. SETTING: Outpatient clinic at one medical center. PARTICIPANTS: 13 healthy volunteers aged 36 to 64 years, receiving medication for hypertension. INTERVENTIONS: Following 24-hour baseline ABPM, participants were randomized to receive either placebo or PPA/B every 12 hours for three doses, while ABPM continued. After a 24-hour washout period, all participants received the crossover regimen. MEASUREMENTS AND MAIN RESULTS: No clinically important or statistically significant difference was noted for mean systolic and diastolic blood pressures during the baseline (125/75), PPA/B (127/72), and placebo (126/73) phases of the study. Within the first four hours of treatment, the mean change in systolic blood pressure from baseline between PPA/B and placebo phases was 1.7 mm Hg (95% CI -5.3 to 8.7), and mean change in diastolic blood pressure was 0.9 mm Hg (95% CI -1.6 to 3.5), excluding a first-dose pressor effect. CONCLUSION: When used as recommended, PPA/B, a commonly used over-the-counter cold medication, has no significant acute effect on blood pressure in patients with controlled hypertension.
|
Authors | A S Petrulis, T F Imperiale, T Speroff |
Journal | Journal of general internal medicine
(J Gen Intern Med)
1991 Nov-Dec
Vol. 6
Issue 6
Pg. 503-6
ISSN: 0884-8734 [Print] United States |
PMID | 1684991
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Delayed-Action Preparations
- Drug Combinations
- Histamine H1 Antagonists
- brompheniramine, pseudoephedrine drug combination
- Phenylephrine
- Phenylpropanolamine
- Pseudoephedrine
- Brompheniramine
|
Topics |
- Blood Pressure
(drug effects)
- Blood Pressure Monitors
- Brompheniramine
(pharmacology)
- Delayed-Action Preparations
- Double-Blind Method
- Drug Combinations
- Female
- Histamine H1 Antagonists
(pharmacology)
- Humans
- Hypertension
(physiopathology)
- Male
- Middle Aged
- Phenylephrine
(pharmacology)
- Phenylpropanolamine
(pharmacology)
- Pseudoephedrine
|